REFERENCES
1. Waldmann TA, Broder S, Krakauer R, MacDermott RP, Durm M, Goldman C
et al. The role of
suppressor cells in the pathogenesis of common variable
hypogammaglobulinemia and the immunodeficiency associated with myeloma.
Fed Proc. 1976; 35: 2067-2072.
2. Siegal FP, Siegal M, Good RA.
Suppression of B-cell
differentiation by leukocytes from hypogammaglobulinemic patients.J
Clin Invest. 1976; 58:109-22.
3. Strelkauskas AJ, Schauf V, Wilson BS, Chess L, Schlossman SF.
Isolation and
characterization of naturally occurring subclasses of human peripheral
blood T cells with regulatory functions. J Immunol. 1978; 120: 1278-82.
4 Gupta S, Schwartz SA,
Good RA. Subpopulations of human T lymphocytes. VII. Cellular basis of
concanavalin A-induced T cell-mediated suppression of immunoglobulin
production by B lymphocytes from normal humans. Cell Immunol. 1979; 44:
242-251.
5. Damle N, Gupta S.
Autologous mixed
lymphocyte reaction in man. V. Functionally and phenotypically distinct
human T-cell subpopulations respond to non-T and activated T cells in
AMLR. Scand J Immunol. 1982; 16: 59-68.
6. Damle NK, Gupta S.
Heterogeneity of
concanavalin A-induced suppressor T cells in man defined with monoclonal
antibodies. Clin Exp Immunol. 1982; 48: 581-588.
7. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunological self
tolerance maintained by activated T cells expressing IL-2 receptor alpha
chain (CD25) Breakdown of a single mechanism of self tolerance causes
various autoimmune diseases. J. Immunol. 1995; 155: 1151-1164
8. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell
development by the transcription factor FoxP3. Science 2003; 299:
1057-1061.
9. Fontenot JD, Gavin MA, Rudensky AY. FoxP3 programs the development
and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003; 4:
330-336.
10. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H et al.
TGF-beta 1 plays an important role in the mechanisms of CD4+CD25+
regulatory cell activity in both humans and mice. J. Immunol. 2004; 172:
834-842.
11. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ,
Whitesell L, et al. The immune dysregulation, polyendocrinopathy,
enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.
Nat. Genet. 2001; 27: 20-21.
12.
Endharti
AT,
Okuno
Y,
Shi
Z,
Misawa
N,
Toyokuni
S,
Ito
M, et al. CD8+CD122+ regulatory T cells (Tregs) and CD4+ Tregs
cooperatively prevent and cure CD4+ cell-induced colitis.
J
Immunol. 2011; 186: 41-52.
13. Lee YH, Ishida Y, Rifa’i M, Shi Z, Isobe K, Suzuki H. Essential role
of CD8+CD122+ Treg in the recovery
from experimental autoimmune encephalomyelitis. J. Immunol. 2008; 180:
825-832.
14. Ménager-Marcq I, Pomié C, Romagnoli P, van Meerwijk JP.
CD8+CD28− regulatory T lymphocytes
prevent experimental inflammatory bowel disease in mice.
Gastroenterology 2006; 131: 1775-1785.
15. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova J L, Buist N,
et al. X-linked neonatal diabetes mellitus, enteropathy and
endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat.
Genet. 2001; 27: 18-20.
16. Chen M-L, Yan B-S, Kozoriz D, Weiner HL. Novel CD8+ Treg suppress
EAE by TGFβ- and IFN-γ-dependent mechanisms. Eur. J. Immunol. 2009; 39:
3423-46.
17. Brimnes J, Allez M, Dotan I, Shao L, Nakazawa A, Myer L. Defect in
CD8+ regulatory T cells in the lamina propria of patients with
inflammatory bowel disease. J. Immunol. 2005; 174: 5814-5822.
18. Tennakoon DK, Mehta RS, Ortega SB, Bhoj V, Racke MK, Karandikar NJ.
Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple
sclerosis. J. Immunol. 2006; 176: 119-126.
19. Shi Z, Okuno Y, Rifa’I M, Endharti AT, Akane K, Isobe K-I, et al.
Human CD8+CCR3+ T cells have same function as murine CD8+CD122+ Treg.
Eur. J. Immunology 2009; 39: 2106-2119.
20. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, et al. Adenosine
generation catabolized by CD39 and CD73 expressed on regulatory T cells
mediate immune suppression. J. Exp. Med. 2004; 1257-1265
21. Chen M-L, Yan B-S, Kozoriz D, and Weiner HL. Novel CD8+ Treg
suppress EAE by TGFβ- and IFN-γ-dependent mechanisms. Eur. J. Immunol.
2009; 39: 3423-3446.
22, Dai H, Wan N, Zhang S, Moore Y, Wan F, Dai Z. Cutting Edge:
Programmed death-1 defines CD8+CD122+ T cells as regulatory versus
memory T cells. J. Immunol. 2010; 124: 1130-1143.
23. Cosmi L, Liotta F, Lazzeri E, Francalanci M, Angeli R, Mazzinghi B
et al. Human CD8+CD25+ thymocytes share phenotypic and functional
features with CD4+CD25+ regulatory thymocytes. Blood 2003; 102:
4107-4114
24 Shou L, Schwartz SA, Good RA.
Suppressor cell
activity after concanavalin A treatment of lymphocytes from normal
donors. J Exp Med. 1976; 143: 1100-1110.
25. Schwartz SA, Choi YS, Shou L, Good RA.
Modulatory effects on
immunoglobulin synthesis and secretion by lymphocytes from
immunodeficient patients. J. Clin. Invest. 1977; 59: 1176-1187
26. Schwartz SA, Shou L, Good RA, Choi YS. Suppression of immunoglobulin
synthesis and secretion by peripheral blood lymphocytes by from normal
donors. Proc. Natl. Acad. Sci. (USA) 1977; 74: 2099-2103.
27. Reinherz EL., Kung PC, Goldstein G, Schlossman SF. A monoclonal
antibody reactive with the human cytotoxic/suppressor T cell subset
previously defined by a hetero antiserum termed TH2. J. Immunol. 1980;
124: 1301-1307.
28. Chang CC, Ciubotariu R, Manavalan JS, Yuan J, Colovai AI, Piazza Fet al. Tolerization of dendritic cells by TS cells: the crucial
role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002;3 : 237-243;
29. Long X, Cheng Q, Liang H, Zhao J, Wang J, Wang W et al.Memory CD4+ T cells are suppressed by CD8+ regulatory T cells in vitro
and in vivo. Am J Transl Res 2017; 9: 63-78
30. Gupta S and Agrawal S. In vitro effect of CD8 Treg on B cell
subsets. Int. Arch. Allergy Immunol. 2020;
31. Louis AG, Agrawal S, Gupta S. Analysis of subsets of B cells, Breg,
CD4 Treg, and CD8 Treg in adult patients with selective IgM deficiency.
Amer. J. Clin. Exp. Immunol. 2017; 5: 21-32.
32. Jarvis LB, Matyszak MK, Duggleby RC, Goodall JC, Hall FC, Gaston JS.
Autoreactive human peripheral blood CD8+ T cells with a regulatory
phenotype and function. Eur. J. Immunol. 2005; 35: 2896-2908.
33. Cai J, Lee J, Jankowska-Gan A, Derks R, Pool J, Mutis T, et al Minor
H antigen HA-1-specific regulator and effector CD8+ T cells and HA-1
microchimerism in allograft tolerance. J. Exp. Med. 2004; 199:
1017-1023.